Perspective Therapeutics (CATX) Cash Flow: Operating & Free Cash Flow

Perspective Therapeutics Cash Flow Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for Perspective Therapeutics, Inc. (CATX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018
Operating Activities
Net Income	-103.12	-79.28	-46.51	-7.27	-7.27	-3.39	-3.45	-6.70
Depreciation & Amortization	3.25	2.31	0.99	0.29	0.15	0.15	0.15	0.08
Deferred Income Tax	-0.79	-2.10	-2.65	0.00	0.00	0.01	0.00	0.00
Stock Based Compensation	8.97	5.22	3.74	1.09	0.39	0.39	0.50	0.61
Change in Working Capital	1.68	31.80	2.92	-1.85	-0.07	-0.07	-0.84	0.22
Change in Accounts Receivable	0.11	1.05	0.20	0.41	0.41	0.03	-0.89	-0.47
Change in Inventory	0.00	0.01	0.36	-2.67	-0.27	-0.27	-0.10	0.02
Change in Accounts Payable	0.15	1.89	1.57	0.24	0.08	0.08	-0.03	0.76
Change in Other Working Capital	0.81	-2.74	4.58	0.05	0.07	0.10	0.18	-0.10
Other Operating Activities	6.74	21.48	4.58	0.02	0.07	0.07	0.00	0.08
Net Cash from Operating Activities	-82.48	-18.29	-36.91	-7.71	-2.84	-2.84	-3.64	-5.71
Investing Activities
Capital Expenditures	-12.75	-54.41	-1.07	-0.27	-0.38	-0.38	-0.27	-0.34
Acquisitions	0.00	0.00	2.70	0.00	0.00	0.00	0.00	0.00
Purchases of Investments	-119.84	-243.51	0.00	-22.69	0.00	0.00	0.00	-4.05
Sales/Maturities of Investments	173.95	78.73	22.76	0.00	0.00	0.00	0.00	6.27
Other Investing Activities	-0.14	-0.07	-0.02	-0.02	-0.02	-0.03	-0.01	-0.02
Net Cash from Investing Activities	41.23	-218.93	24.37	-0.28	-0.41	-0.41	-0.29	1.86
Financing Activities
Debt Repayment	-0.05	-0.05	-0.07	0.00	0.00	0.00	0.00	0.00
Common Stock Issued	10.36	289.43	0.36	0.06	64.16	64.69	1.01	0.48
Dividends Paid	0.00	0.00	0.00	0.00	-0.01	-0.01	-0.01	-0.01
Other Financing Activities	0.00	12.25	-0.07	0.03	0.00	0.00	0.00	0.05
Net Cash from Financing Activities	10.31	289.39	0.79	0.06	64.68	64.68	0.99	0.52
Summary
Net Change in Cash	-30.95	52.16	-11.76	-7.94	61.44	61.44	-2.93	-3.33
Cash at Beginning of Period	61.58	9.42	21.18	64.01	2.57	2.57	5.51	6.11
Cash at End of Period	30.63	61.58	9.42	56.07	64.01	64.01	2.57	2.78
Free Cash Flow	-95.23	-72.71	-37.99	-7.98	-3.22	-3.22	-3.91	-6.05

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Perspective Therapeutics Cash Flow

What is Perspective Therapeutics's free cash flow?

Perspective Therapeutics had negative free cash flow of $95.23M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$82.48M minus $12.75M of capital expenditures.

How much does Perspective Therapeutics spend on capital expenditures?

Perspective Therapeutics spent $12.75M on capital expenditures in fiscal 2025, compared with $54.41M a year earlier.

Does Perspective Therapeutics pay dividends or buy back shares?

Perspective Therapeutics's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition